Logo
x

Search

Subscribe Now

Roche

Oxford BioTherapeutics and Roche Collaborate to Discover Next-Gen Biologics for Cancer Treatment

Oxford BioTherapeutics and Roche Collaborate to Discover Next-Gen Biologics for Cancer Treatment

  • March 20, 2025
Roche Reports the US FDA’s Approval of Susvimo to Treat Diabetic Macular Edema (DME)

Roche Reports the US FDA’s Approval of Susvimo to Treat Diabetic Macular Edema (DME)

  • February 5, 2025
Roche Reports Topline Data from P-III (INAVO120) Trial of Itovebi (Inavolisib) to Treat HR-Positive Breast Cancer

Roche Reports Topline Data from P-III (INAVO120) Trial of Itovebi (Inavolisib) to Treat HR-Positive Breast Cancer

  • January 30, 2025
Roche Reveals Data from P-III (EMBARK) Study of Elevidys in Ambulatory Boys with Duchenne Muscular Dystrophy

Roche Reveals Data from P-III (EMBARK) Study of Elevidys in Ambulatory Boys with Duchenne Muscular Dystrophy

  • January 28, 2025
Roche Receives 510(k) Clearance & CLIA Waiver for Cobas Liat Multiplex Assay Panels to Diagnose Sexually Transmitted Infections

Roche Receives 510(k) Clearance & CLIA Waiver for Cobas Liat Multiplex Assay Panels to Diagnose Sexually Transmitted Infections

  • January 22, 2025
Roche Reports the P-IIb (PADOVA) Trial Data of Prasinezumab for Early-Stage Parkinson’s Disease

Roche Reports the P-IIb (PADOVA) Trial Data of Prasinezumab for Early-Stage Parkinson’s Disease

  • December 20, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.